OWM
Opes Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Hold |
14,445
| – | – | 0.05% | 122 |
|
|
2025
Q1 | $296K | Buy |
14,445
+4,200
| +41% | +$86.1K | 0.06% | 119 |
|
|
2024
Q4 | $232K | Hold |
10,245
| – | – | 0.05% | 125 |
|
|
2024
Q3 | $252K | Hold |
10,245
| – | – | 0.05% | 118 |
|
|
2024
Q2 | $237K | Hold |
10,245
| – | – | 0.05% | 120 |
|
|
2024
Q1 | $247K | Buy |
10,245
+1,400
| +16% | +$33.7K | 0.06% | 117 |
|
|
2023
Q4 | $204K | Buy |
+8,845
| New | +$204K | 0.05% | 124 |
|
|
2022
Q4 | – | Sell |
-7,595
| Closed | -$200K | – | 106 |
|
|
2022
Q3 | $200K | Buy |
+7,595
| New | +$200K | 0.08% | 90 |
|
|
2022
Q2 | – | Sell |
-6,595
| Closed | -$227K | – | 97 |
|
|
2022
Q1 | $227K | Buy |
6,595
+1,175
| +22% | +$40.4K | 0.07% | 95 |
|
|
2021
Q4 | $237K | Buy |
+5,420
| New | +$237K | 0.07% | 99 |
|